Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-29 Sale | 2024-01-31 4:28 pm | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 1,250 | $65.12 | $81,402 | 46,387 (Direct) | View |
| 2024-01-23 Sale | 2024-01-24 4:06 pm | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 4,286 | $63.69 | $272,975 | 47,637 (Direct) | View |
| 2024-01-22 Sale | 2024-01-23 6:07 pm | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 1,738 | $65 | $112,963 | 51,923 (Direct) | View |
| 2024-01-17 Sale | 2024-01-18 4:54 pm | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 3,276 | $65.58 | $214,840 | 53,661 (Direct) | View |
| 2024-01-16 Sale | 2024-01-17 4:43 pm | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 1,632 | $66.81 | $109,032 | 81,603 (Direct) | View |
| 2023-06-01 Sale | 2023-06-02 4:40 pm | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 5,000 | $86 | $430,000 | 147,504 (Direct) | View |
| 2023-04-03 Sale | 2023-04-05 4:52 pm | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 5,000 | $75 | $375,000 | 152,430 (Direct) | View |
| 2023-02-23 Sale | 2023-02-27 4:32 pm | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 1,104 | $68.76 | $75,911 | 41,430 (Direct) | View |
| 2023-01-30 Sale | 2023-01-31 4:47 pm | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 883 | $52.76 | $46,587 | 36,459 (Direct) | View |
| 2023-01-23 Sale | 2023-01-25 4:17 pm | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 2,955 | $51.58 | $152,419 | 37,709 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-16 Option Award | 2024-01-17 4:43 pm | N/A 2034-01-15 | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 24,666 | $66.3 | 81,603 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-17 4:43 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 16,963 | $0 | 81,603 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-02 4:40 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 5,000 | $34.11 | 147,504 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-02 4:40 pm | N/A 2030-05-03 | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 5,000 | $0 | 147,504 (Direct) | View |
| 2023-04-03 Exercise | 2023-04-05 4:52 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 5,000 | $34.11 | 152,430 (Direct) | View |
| 2023-04-03 Exercise | 2023-04-05 4:52 pm | N/A 2030-05-03 | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 5,000 | $0 | 152,430 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-22 06:50 am | N/A 2033-01-20 | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 16,030 | $0 | 51,936 (Direct) | View |
| 2023-02-21 Tax Withholding | 2023-02-22 06:50 am | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 553 | $58.5 | 51,936 (Direct) | View |
| 2023-01-27 Tax Withholding | 2023-01-30 5:01 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 367 | $52.77 | 37,342 (Direct) | View |
| 2023-01-20 Tax Withholding | 2023-01-24 5:20 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 1,411 | $52.05 | 40,664 (Direct) | View |
| 2022-04-25 Other | 2023-01-17 7:39 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 8,750 | $0 | 74,170 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 7:39 pm | N/A 2033-01-11 | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 30,845 | $52.66 | 74,170 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 7:39 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 19,634 | $0 | 74,170 (Direct) | View |
| 2022-01-28 Tax Withholding | 2022-02-01 5:59 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 434 | $38.59 | 23,474 (Direct) | View |
| 2022-01-21 Option Award | 2022-01-25 4:40 pm | N/A 2032-01-20 | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 42,240 | $0 | 48,682 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:37 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 43,750 | $0 | 43,750 (Direct) | View |
Ownership | 2020-06-09 6:07 pm | N/A 2030-05-03 | Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer | 0 | $0 | 116,000 (Direct) | View |